Mar 02, 2021 9:15am EST Processa Pharmaceuticals Announces Closing of a $10.2 Million Private Placement
Jan 11, 2021 10:50am EST Processa Pharmaceuticals to Present at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference
Nov 12, 2020 5:02pm EST Processa Pharmaceuticals Announces Third Quarter 2020 Results, Provides Corporate Update
Nov 05, 2020 9:15am EST Processa Pharmaceuticals Announces the Appointment of Dr. Khalid Islam to Its Board of Directors
Nov 03, 2020 9:20am EST Processa Pharmaceuticals Schedules Conference Call to Discuss Third Quarter Results and Provide Drug Development Update on Nov. 12 at 5:30 p.m. ET
Oct 13, 2020 9:30am EDT Processa Pharmaceuticals Announces Appointment of Michael Floyd as Chief Operating Officer
Oct 02, 2020 6:00am EDT Processa Pharmaceuticals Announces Pricing of $19.2 Million Public Offering and Uplisting to the Nasdaq Capital Market
